CrossAssetDataThe Company File
···
STEX

Streamex Corp.

Streamex Corp. is classed by the SEC under Electromedical & Electrotherapeutic Apparatus (industry code 3845), based in Winter Park, FL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $40 thousand and a loss of $463 million (its filed statements).

Product business Electromedical & Electrotherapeutic Apparatus Winter Park, FL filings since 2011 4 of 9 filed, 5 estimated
Ask the desk about STEX → Compare STEX with CBLL → Price chart on TradingView ↗ Full EDGAR file ↗ Watch STEX →

Sector peers: CBLLAXGNOMBLFS

3.4/10headline grade
vs its business-model standard
3.3/10past 2.9/10present 4.3/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3845, Electromedical & Electrotherapeutic Apparatus); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 3.4 out of ten, 4 of 9 metrics filed and 5 estimated: past 3.3 out of ten, present 2.9 out of ten, future 4.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 1.3 out of ten. 20 warning events since 2017; the latest 2026-10-09. 13th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.5 out of ten. CrossAssetData estimate 5.5/10, confidence 20 of 100 (family median). 50th percentile among 25 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Shareholder treatment (past): 1.7 out of ten. CrossAssetData estimate 1.7/10, confidence 35 of 100 (one part). 17th percentile among 27 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 3.3 out of ten. ROE -347%: lost 347¢ per shareholder dollar. Leverage 29%: owes 29¢ per asset dollar. 33rd percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 3.3 out of ten. bottom 33% of 24 in its family; net margin -25825%. 33rd percentile among 24 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 1.3 out of ten. bottom 13% of 19 in its family for leadership; chief executive since 2025. 13th percentile among 19 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 3.3 out of ten. CrossAssetData estimate 3.3/10, confidence 35 of 100 (one part). 33rd percentile among 27 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Growth drivers (future): 5.0 out of ten. CrossAssetData estimate 5.0/10, confidence 20 of 100 (family median). 50th percentile among 25 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
  • Expectations vs reality (future): 5.4 out of ten. CrossAssetData estimate 5.4/10, confidence 20 of 100 (family median). 50th percentile among 20 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.

The filing record

Newest annual report: Form 10-K filed 2026-03-31 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-14 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-09-30 for the period ended 2026-09-24 (on EDGAR). Newest filing: Form 8-K, 2026-10-09. Filings on record since 2011. Read from EDGAR 2026-10-12.

Who runs it

Mcphie, Karl Henry Michael (CEO); Lekstrom, Morgan Lee (Interim Executive Chairman); Plummer, Christine Marie (Chief Financial Officer); Groenewald, Ferdinand (CFO); Williams, Mitchell Young (Chief Investment Officer); Gopaul, Kevin Roy (director); Matthews, Shawn (director); Marciano, Anthony Mark (director); Browne, Donald (director). 9 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-07.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.